Exit Text Mode

Macular Disease Foundation Australia logo

    MDFA News

    New Nutrition Guidelines for AMD

    Latest research supports Mediterranean and Asian-style eating plans to reduce risk of AMD

    Read more
    Back

    Most recent

     “I’ll work until they put me in a pine box”

    Mike can’t retire because he wouldn’t be able to afford the cost of eye treatment that prevents him from going blind.

    “Rural ophthalmologists are overloaded with patients. We need more specialists out here”

    People who live in rural and remote areas face real struggles to commit to start sight-saving eye injections and to stick with the treatment.

    “The cost of my eyes has prohibited us from going on any kind of holiday”

    My eyes are our holiday money. I’ve even considered giving up my injections. It’s a

    MDFA launches new economic modelling

    MDFA launches new economic modelling

    My Eyes offers a new way to support AMD patients.

    My Eyes offers a new way to support AMD patients.

    Evaluation of MDFA’s education courses for health professionals

    Evaluation of MDFA’s education courses for health professionals

    Partnership to address Diabetic Eye Disease in Indigenous communities

    A successful project to train practitioners to screen for diabetic eye disease in Indigenous communities across Australia has been extended.

    New stem cell models for dry AMD

    A years-long collaboration between some of Australia’s leading experts in stem cell biology, ophthalmology, and computational biology has produced a genetic roadmap for age-related macular degeneration (AMD) that could be a gamechanger for the discovery of novel treatments.

    Vabysmo® (faricimab) now available in Australia 

    Vabysmo is a new treatment for age-related macular degeneration and diabetic macular oedema and is now available on the Pharmaceutical Benefits Scheme (PBS) in Australia

    Loading...
    Loading...